東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Biliary tract- Diseases." ]

切換: 標籤 | MARC模式 | ISBD

Biliary disease = from science to cl...

Hirschfield, Gideon.

FindBook

Google Book

Amazon

博客來

Biliary disease = from science to clinic /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Biliary disease/ edited by Gideon Hirschfield, David Adams, Evaggelia Liaskou.
其他題名:	from science to clinic /
其他作者:	Hirschfield, Gideon.
出版者:	Cham :Springer International Publishing : : 2017.,
面頁冊數:	viii, 264 p. :ill., digital ;24 cm.
內容註:	The clinical burden of biliary disease- a global perspective -- The healthy biliary tree- cellular and immunobiology -- Bile acid signalling and the current understanding of cholestasis: new opportunities for treatments? -- Animal models of biliary disease- current approaches and limitations -- The microbiome and human disease- a new organ of interest in biliary disease? -- Progressive familial intrahepatic cholestatic syndromes- genetic insights into biliary transporter function -- Biliary atresia- from pathology to treatment -- Drug induced cholestasis: mechanisms and importance -- Primary biliary cirrhosis- it's science and practice -- Primary sclerosing cholangitis- current concepts in biology and strategies for new therapy -- Cholangiocarcinoma- evaluation of risk and new treatment paradigms -- Gallstone disease in the 21st century: practice and controversies -- Autoimmune sclerosing cholangitis/IgG4 cholangiopathy- new diseases? -- Conclusions and future opportunities.
Contained By:	Springer eBooks
標題:	Biliary tract - Diseases. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-50168-0
ISBN:	9783319501680

Biliary disease = from science to clinic /
Biliary diseasefrom science to clinic /[electronic resource] :edited by Gideon Hirschfield, David Adams, Evaggelia Liaskou. - Cham :Springer International Publishing :2017. - viii, 264 p. :ill., digital ;24 cm.

The clinical burden of biliary disease- a global perspective -- The healthy biliary tree- cellular and immunobiology -- Bile acid signalling and the current understanding of cholestasis: new opportunities for treatments? -- Animal models of biliary disease- current approaches and limitations -- The microbiome and human disease- a new organ of interest in biliary disease? -- Progressive familial intrahepatic cholestatic syndromes- genetic insights into biliary transporter function -- Biliary atresia- from pathology to treatment -- Drug induced cholestasis: mechanisms and importance -- Primary biliary cirrhosis- it's science and practice -- Primary sclerosing cholangitis- current concepts in biology and strategies for new therapy -- Cholangiocarcinoma- evaluation of risk and new treatment paradigms -- Gallstone disease in the 21st century: practice and controversies -- Autoimmune sclerosing cholangitis/IgG4 cholangiopathy- new diseases? -- Conclusions and future opportunities.

This book addresses the current understanding of the diagnosis and management of biliary disease across all ages, with emphasis on how the latest advances in clinical science may be integrated into current and future therapies. The coverage is wide ranging, encompassing congenital and acquired conditions including cholestatic syndromes, biliary atresia, drug-induced cholestasis, primary biliary cholangitis/cirrhosis, primary sclerosing cholangitis, cholangiocarcinoma, gallstone disease, and autoimmune sclerosing cholangitis. With contributions from basic and clinical scientists, the relevance of state-of-the-art mechanistic biology to diagnosis, treatment, and future opportunities for drug design is clearly explained. The balance between science and clinical practice will ensure that this book makes a lasting contribution to the field. A broad readership will find the book easy to access and a rich source of information on current best practice and evolving management strategies.

ISBN: 9783319501680

Standard No.: 10.1007/978-3-319-50168-0doiSubjects--Topical Terms:

927967
Biliary tract
--Diseases.

LC Class. No.: RC845

Dewey Class. No.: 616.36

Biliary disease = from science to clinic /
LDR:02927nmm a2200313 a 4500 001 2090484
003 DE-He213
005 20170830095926.0
006 m d
007 cr nn 008maaau
008 171013s2017 gw s 0 eng d
020 $a 9783319501680 $q (electronic bk.)
020 $a 9783319501666 $q (paper)
024 7 $a 10.1007/978-3-319-50168-0 $2 doi
035 $a 978-3-319-50168-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RC845
072 7 $a MJH $2 bicssc
072 7 $a MED031000 $2 bisacsh
082 0 4 $a 616.36 $2 23
090 $a RC845 $b .B595 2017
245 0 0 $a Biliary disease $h [electronic resource] : $b from science to clinic / $c edited by Gideon Hirschfield, David Adams, Evaggelia Liaskou.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2017.
300 $a viii, 264 p. : $b ill., digital ; $c 24 cm.
505 0 $a The clinical burden of biliary disease- a global perspective -- The healthy biliary tree- cellular and immunobiology -- Bile acid signalling and the current understanding of cholestasis: new opportunities for treatments? -- Animal models of biliary disease- current approaches and limitations -- The microbiome and human disease- a new organ of interest in biliary disease? -- Progressive familial intrahepatic cholestatic syndromes- genetic insights into biliary transporter function -- Biliary atresia- from pathology to treatment -- Drug induced cholestasis: mechanisms and importance -- Primary biliary cirrhosis- it's science and practice -- Primary sclerosing cholangitis- current concepts in biology and strategies for new therapy -- Cholangiocarcinoma- evaluation of risk and new treatment paradigms -- Gallstone disease in the 21st century: practice and controversies -- Autoimmune sclerosing cholangitis/IgG4 cholangiopathy- new diseases? -- Conclusions and future opportunities.
520 $a This book addresses the current understanding of the diagnosis and management of biliary disease across all ages, with emphasis on how the latest advances in clinical science may be integrated into current and future therapies. The coverage is wide ranging, encompassing congenital and acquired conditions including cholestatic syndromes, biliary atresia, drug-induced cholestasis, primary biliary cholangitis/cirrhosis, primary sclerosing cholangitis, cholangiocarcinoma, gallstone disease, and autoimmune sclerosing cholangitis. With contributions from basic and clinical scientists, the relevance of state-of-the-art mechanistic biology to diagnosis, treatment, and future opportunities for drug design is clearly explained. The balance between science and clinical practice will ensure that this book makes a lasting contribution to the field. A broad readership will find the book easy to access and a rich source of information on current best practice and evolving management strategies.
650 0 $a Biliary tract $x Diseases. $3 927967
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Gastroenterology. $3 828956
650 2 4 $a Hepatology. $3 894467
650 2 4 $a Pediatrics. $3 559143
650 2 4 $a Nursing. $3 528444
650 2 4 $a Pathology. $3 643180
650 2 4 $a Imaging / Radiology. $3 891022
700 1 $a Hirschfield, Gideon. $3 3222064
700 1 $a Adams, David. $3 591951
700 1 $a Liaskou, Evaggelia. $3 3222065
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-50168-0
950 $a Medicine (Springer-11650)